Quarterly ResultAug 5, 2026, 04:15 PM
Insulet Q2 Revenue $801.7M, Net Income $95.0M, EPS $1.37
AI Summary
Insulet Corporation reported strong financial results for the second quarter and first six months of 2026. Revenue for Q2 2026 increased by 23.5% to $801.7 million, with net income soaring by 322.2% to $95.0 million and diluted EPS reaching $1.37. The company also announced an extension of its share repurchase program and the approval of an additional $350 million for repurchases, following the completion of $300 million in accelerated share repurchases earlier in the year. A significant legal development saw the Federal Circuit reverse a prior trade secret judgment against EOFlow, which had no impact on Insulet's consolidated financial statements as damages were not previously accrued.
Key Highlights
- Q2 2026 Revenue increased 23.5% to $801.7 million from $649.1 million in Q2 2025.
- Q2 2026 Net Income surged 322.2% to $95.0 million from $22.5 million in Q2 2025.
- Q2 2026 Diluted EPS rose 328.1% to $1.37 from $0.32 in Q2 2025.
- Board extended $125 million share repurchase program and approved an additional $350 million.
- Completed $300 million accelerated share repurchase agreements by March 31, 2026.
- Federal Circuit reversed $59.4 million trade secret judgment in Insulet v. EOFlow case.
- Six months ended June 30, 2026, revenue increased 28.3% to $1,563.4 million.
- Cash and cash equivalents were $534.9 million as of June 30, 2026.
Price Impact
More from PODD